Ventripoint Diagnostics Reveals New Convertible Debenture Offering

VentriPoint Diagnostics (TSE:VPT) has released an update.

Ventripoint Diagnostics Ltd. has announced a revised non-brokered private placement offering of unsecured convertible debentures worth up to CDN$1,000,000. The debentures, convertible at various price points over the years, aim to attract investors with a 10% annual interest rate and potential automatic conversion into common shares under specific conditions.

For further insights into TSE:VPT stock, check out TipRanks’ Stock Analysis page.